Recent Research Funding

Strong funding from many sources supports research in our division.

Backed by grants from foundations, institutes, companies, programs and organizations, our physician-scientists engage in various areas of research and conduct innovative studies.

We’ve received competitively awarded funding from sources such as:

  • National Institutes of Health
  • GlaxoSmithKline
  • United States Department of Veterans Affairs
  • National Kidney Foundation
  • Arthritis Foundation
  • NephroGenex, Inc.
  • Agency for Healthcare Research and Quality
  • Amgen
  • R01 DK114485 Computational Imaging of Renal Structures for Diagnosing Diabetic Nephropathy. Rabi Yacoub (Co-Investigator). National Institutes of Health (NIH) NIDDK/NIH. $993,750. 9/1/2018-7/1/2023.
  • Age and Race Influences on Immunosuppression after Renal Transplant:. Brian Murray (Co-Investigator). National Institute of Aging. $3,500,000. 8/1/2019-6/1/2023.
  • NIH R01. Jessy Alexander (Principal Investigator). National Institute of Health. $717,750. 7/1/2018-7/1/2021.
  • Computational analysis of neutrophil extracellular traps in lupus nephritis renal biopsies. Rabi Yacoub (Co-Investigator). NIDDK/NIH, CKD Biomarkers Consortium BioCon Pilot Studies. $50,000. 7/1/2019-6/1/2020.
  • Real-Time Dynamics of Drug-Induced Nephrotoxicity. Rabi Yacoub (Co-Investigator). Clinical and Translational Science Institute Pilot studies. $50,000. 4/1/2019-3/1/2020.